Search

Displaying results 5561 - 5570 of 10000 in total
  1. Drug

    Tilia cordata pollen

    go.drugbank.com/drugs/DB10954
    Approved

    Tilia cordata pollen is mainly used in allergenic testing.

  2. Drug

    Hordeum vulgare pollen

    go.drugbank.com/drugs/DB10961
    Approved

    Hordeum vulgare pollen is mainly used in allergenic testing.

  3. Drug

    Pseudotsuga menziesii pollen

    go.drugbank.com/drugs/DB10986
    Approved

    Pseudotsuga menziesii pollen is mainly used in allergenic testing.

  4. Drug

    Maclura pomifera pollen

    go.drugbank.com/drugs/DB10988
    Approved

    Maclura pomifera pollen is mainly used in allergenic testing.

  5. Drug

    JNJ-42165279

    go.drugbank.com/drugs/DB15173
    Investigational

    Jnj-42165279 is under investigation in clinical trial NCT02498392 (An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious Distress).

  6. Drug

    Tesaglitazar

    go.drugbank.com/drugs/DB06536
    Investigational

    Tesaglitazar is a dual peroxisome proliferator-activated receptor alpha/gamma agonist which improves apolipoprotein levels in non-diabetic subjects with insulin resistance. … Tesaglitazar is a proposed treatment for type 2 diabetes and has completed several phase III clinical trials, however in May 2006 AstraZeneca announced that they had discontinued further development.

  7. Drug

    M0002

    go.drugbank.com/drugs/DB05091
    Investigational

    M0002 is an orally-active selective vasopressin antagonist that inhibits water re-absorption from the kidneys.

  8. Drug

    Verubecestat

    go.drugbank.com/drugs/DB12285
    Investigational

    In the study, administration of Verubecestat at doses of 12, 40 and 60 mg resulted in a dose-dependent and sustained reduction in the levels of Ab40, a measure of BACE1 activity, in CSF from baseline of … In July 2013, Merck announced positive results for Phase Ib trials of Verubecestat.

  9. Drug

    Amylopectin

    go.drugbank.com/drugs/DB14927
    Experimental

    Amylopectin is under investigation in clinical trial NCT01708694 (Role of Slowly Digesible Starch on Diabetes Risk Factors).

  10. Drug

    Cafedrine

    go.drugbank.com/drugs/DB12926
    Investigational

    Cafedrine is under investigation in clinical trial NCT01311414 (Effect of Cafedrine/Theodrenaline and Urapidil on Cerebral Oxygenation).